定向进化
定向分子进化
细菌
酶
计算生物学
合成生物学
体内
蛋白质工程
生物
功能(生物学)
生物技术
生物化学
遗传学
基因
突变体
作者
Rudy Rubini,Suzanne C. Jansen,H Beekhuis,H.J. Rozeboom,Clemens Mayer
标识
DOI:10.1002/anie.202213942
摘要
Abstract In vivo selections are powerful tools for the directed evolution of enzymes. However, the need to link enzymatic activity to cellular survival makes selections for enzymes that do not fulfill a metabolic function challenging. Here, we present an in vivo selection strategy that leverages recoded organisms addicted to non‐canonical amino acids (ncAAs) to evolve biocatalysts that can provide these building blocks from synthetic precursors. We exemplify our platform by engineering carbamoylases that display catalytic efficiencies more than five orders of magnitude higher than those observed for the wild‐type enzyme for ncAA‐precursors. As growth rates of bacteria under selective conditions correlate with enzymatic activities, we were able to elicit improved variants from populations by performing serial passaging. By requiring minimal human intervention and no specialized equipment, we surmise that our strategy will become a versatile tool for the in vivo directed evolution of diverse biocatalysts.
科研通智能强力驱动
Strongly Powered by AbleSci AI